Skip to main content

Aseptic Processing Area and Its Maintenance

Aseptic Processing Area and Its Maintenance

It is critical to maintain the aseptic manufacturing area because a lot of things may cause contamination in area including the personnel working in the area. A small contamination in area may cause contamination in whole batch.

Good manufacturing practices and regulations are critical areas for having good practices for the pharmaceutical industry. Much care should betaken especially when manufacturing sterile drugs and other biological products using aseptic processing. A critical area is where sterilized drugs,containers and closures may be exposed to the external conditions, therefore must be designed and manufactured to keep the product sterility.

Why is this so? Because an exposed product is vulnerable to contamination. It may also not be sterilized in its immediate container. Therefore, the quality of an environment in which aseptic operations are being conducted, should be controlled and well maintained. The air quality should be properly controlled especially, the particles its carries.

There is a need for supporting clean areas, as these serve as zones where non-sterile components, in-process materials, equipment and containers are held and transferred. The need is therefore to have clean working environments that minimize the level of particle contaminants in the final product before they are sterilized.

Another critical issue is ensuring clean area separation. Its an essential part of preventing the contamination when processing drugs. Airflow which ensures the quality of areas of higher cleanliness to those other areas that are less clean. A positive pressure of differential at least of 10-15 Pascal(Pa) must be maintained between the adjacent rooms with closed doors. Monitoring of these air pressure differentials should be monitored frequently from one shift to another. Additionally, air filtration should be carried out using HEPA filters to ensure that air inside the rooms is equal or better than that of the air in the environment into which the air is introduced.

Over and above, the design process is a critical area in the pharmaceutical industry. Aseptic processes should minimize the exposure of sterile articles to the potential hazards of contamination during the manufacturing operation. Issues that you should notice include well-designed processes in limiting the duration of exposure of sterile products, good environment control measures, process flow optimizations, good designing of equipment to prevent lower quality air entry is critical areas. Also, personnel and material flow need to be optimized to reduce and prevent activities that may introduce contaminants to the exposed product.

Well maintained, designed and operated aseptic process minimizes personnel intervention. Using good aseptic techniques at all times ensures the maintenance of product sterility. For personnel, appropriate training should be conducted before the individual be permitted to access some of the critical areas in the process. Training topics should include hygiene, safety hazards, specific written procedures, regular ongoing programs, aseptic filling technique, clean-room behavior, microbiology etc.

Lastly, it would be worth to note that some major techniques of maintaining sterility of all items and surfaces which are critical areas may include: 

  • Contacting sterile materials with sterile instruments only.
  • Slow movements to avoid any disruptions to control parameters
  • Keep your entire body out of the path of unidirectional airflow so that to protect sterile equipment, product and container closures from contamination.
  • Maintain proper gowning to control any form of human-generated contamination.

Comments

Popular posts from this blog

Checklist for Audit in Sterile Area

Checklist for Audit in Sterile Area Checklist to verify the sterile manufacturing area before the audit. 1. Is there any SOP giving details for activity/ movement in the sterile area. 2. Verify the suitability of system for sanitization of hands. 3. Is there the SOP on entry-exit; gowning and de-gowning into the critical area available? 4. Verify the availability of following records:  Air pressure differential  Particulate monitoring  Temperature  Humidity  Microbiological monitoring by settle plate 5. Are these records available and maintained as per SOPs? 6. Check the above mentioned individual records. Are the entries within specifications mentioned in SOP/ MTPs. 7. Is the controlled copy of MTP pertaining to monitoring by settle plate available to plant person? 8. Are the location for settle plates identified and the chart/ layout available with plant? 9. Are the following areas monitored for parameters mentioned in step 4:  Air-lock to the critical ar...

Aseptic Filling Process (Media Fill) Validation Protocol in Sterile Pharmaceuticals

Aseptic Filling Process (Media Fill) Validation Protocol in Sterile Pharmaceuticals Validation of sterile manufacturing process by media fill validation test as per PICS guidelines for aseptic validation or aseptic process simulation. 1.0 OBJECTIVE 1.1 To define procedures for validating and maintaining the validation of all aseptic filling processes and qualification of the quality of the product by system/facility/equipment. 2.0 SCOPE 2.1 This procedure applies to all aseptically filled sterile products intended for human use. 3.0 RESPONSIBILITY 3.1 The Validation personnel coordinate the aseptic filling validation program and write the sterile media aseptic filling processes reports. 3.2 Manufacturing personnel the sterile media aseptic filling processes and performs the sterile media fills. 3.3 QA personnel perform the sampling and assist with the IPQA monitoring required for each sterile media fill. 3.4 QC personnel to perform the testing and assist with the monitoring required fo...

Blow Fill Seal (BFS) and Form Fill Seal (FFS) Technology in Sterile Manufacturing

Blow Fill Seal (BFS) and Form Fill Seal (FFS) Technology in Sterile Manufacturing Know about sterile pharmaceutical production using Blow Fill Seal (BFS) and Form Fill Seal (FFS) technology. Both of these techniques are used to manufacture  sterile pharmaceutical products   as parenteral (LVP & SVP), infusions, ophthalmic and inhalation products. These are automated techniques to prepare sterile products. The basic concept of the  FFS   and BFS is to reduce the  contamination   by forming the container, filling and sealing in a closed sterile chamber of the machine. There is no personnel intervention to reduce the chances of the contamination during the manufacturing of sterile products. It gives more production at very low operational cost with the high assurance of  sterility . Blow fill seal technology is widely used and accepted by the various pharmaceutical regulatory authorities as US-FDA and MHRA. The system is being used for over 30 years a...